This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brooks, R. A. Articles by Winton, D. J. Search for Related Content PubMed PubMed Citation Articles by Brooks, R. A. Articles by Winton, D. J.

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Is a Potent Mutagen in the Mouse Small Intestine¹

Cancer Research Campaign Human Cancer Genetics Research Group, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP [R. A. B., L. A. H., D. J. W.], and Department of Clinical Pharmacology, Royal Postgraduate Medical School, DuCane Road, London W12 0NN [N. J. G., K. Z., R. J. E., A. R. B.], United Kingdom

Mutations in long lived stem cells are critical events in carcinogenesis. The Dlb-1 assay detects intestinal stem cell mutation at the Dlb-1 locus in Dlb-1^a/b heterozygous mice by visualizing mutated clones of epithelial cells in situ which do not bind the lectin Dolichos biflorus agglutinin. We have used this assay to show that the food-derived heterocyclic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a potent intestinal mutagen when administered either i.p. or p.o. This contrasts with the inactivity of the structurally related mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in the assay which we have described previously. Immunocytochemical localization of the P-450 enzyme CYP1A2, which is responsible for the primary activation of these mutagens, shows that in untreated mice it is present in liver hepatocytes and in occasional villus epithelial cells but is absent from the target intestinal stem cell population. In addition, liver microsomes, unlike intestinal microsomes, were able to convert PhIP to the proximate mutagen N-hydroxy-PhIP. CYP1A2 immunoreactivity in ß-napthoflavone-induced animals was elevated in liver hepatocytes and increased to a lesser extent in duodenal villus epithelial cells. Treatment with ß-napthoflavone produced an unexpected 46% decrease in the number of Dlb-1 mutations in response to PhIP. Following treatment with PhIP, there was no difference in the number of Dlb-1 locus mutations between the proximal and distal ends of the small intestine in uninduced animals, indicating that the bile duct is unlikely to be responsible for transport of mutation inducing metabolites of PhIP to the small intestine. Our results demonstrate that metabolic activation of an indirect acting genotoxic agent can occur at a site other than the target tissue, and absence of the enzymes required for activation of a mutagen does not necessarily protect that tissue from its genotoxic effects.

¹ This study was supported by the Cancer Research Campaign.

² To whom requests for reprints should be addressed.

Received 9/17/93. Accepted 1/26/94.

This article has been cited by other articles:

				I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, A. Andreassen, and J. Alexander Intestinal Tumorigenesis in Multiple Intestinal Neoplasia Mice Induced by the Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal Susceptibility, Regional Variation, and Correlation with DNA Adducts Cancer Res., December 1, 2001; 61(24): 8689 - 8696. [Abstract] [Full Text] [PDF]

				A. Andreassen, R. Vikse, I.-L. Steffensen, J. E. Paulsen, and J. Alexander Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele Mutagenesis, July 1, 2001; 16(4): 309 - 315. [Abstract] [Full Text] [PDF]

				G. P. Collett, C. N. Robson, J. C. Mathers, and F. C. Campbell Curcumin modifies Apcmin apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apcmin mice Carcinogenesis, May 1, 2001; 22(5): 821 - 825. [Abstract] [Full Text] [PDF]

				J.C. Klein, R.B. Beems, P.E. Zwart, M. Hamzink, G. Zomer, H.v. Steeg, and C.F.v. Kreijl Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in DNA repair deficient XPA-/- mice Carcinogenesis, April 1, 2001; 22(4): 619 - 626. [Abstract] [Full Text] [PDF]

				J. A. Heddle, M. G. Knize, D. Dawod, and X.-B. Zhang A test of the mutagenicity of cooked meats in vivo Mutagenesis, March 1, 2001; 16(2): 103 - 107. [Abstract] [Full Text] [PDF]

				J. E. Paulsen, I.-L. Steffensen, A. Andreassen, R. Vikse, and J. Alexander Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice Carcinogenesis, July 1, 1999; 20(7): 1277 - 1282. [Abstract] [Full Text] [PDF]

				W. Pfau, F. L. Martin, K. J. Cole, S. Venitt, D. H. Phillips, P. L. Grover, and H. Marquardt Heterocyclic aromatic amines induce DNA strand breaks and cell transformation Carcinogenesis, April 1, 1999; 20(4): 545 - 551. [Abstract] [Full Text] [PDF]

				H. A.J. Schut and E. G. Snyderwine DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis Carcinogenesis, March 1, 1999; 20(3): 353 - 368. [Abstract] [Full Text] [PDF]

				R. A. Brooks, N. J. Gooderham, R. J. Edwards, A. R. Boobis, and D. J. Winton The mutagenicity of benzo[a]pyrene in mouse small intestine Carcinogenesis, January 1, 1999; 20(1): 109 - 114. [Abstract] [Full Text] [PDF]

				R. Brooks and D. Winton Determination of spatial patterns of DNA damage and repair in intestinal crypts by multi-cell gel electrophoresis J. Cell Sci., January 8, 1996; 109(8): 2061 - 2068. [Abstract] [PDF]